Cytokinetics reported $115.42M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 204.92M 57.48M
Acorda Therapeutics ACOR:US $ 31.87M 13.76M
Amgen AMGN:US $ 6528M 1461M
Arca Biopharma ABIO:US $ 53.36M 13.57M
Bayer BAYN:GR € 5785M 1221M
Biogen BIIB:US $ 1749.3M 512.1M
Brainstorm Cell Therapeutics BCLI:US $ 15.15M 3.7M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Capricor Therapeutics CAPR:US $ 58.33M 23.45M
Cytokinetics CYTK:US $ 115.42M 2.76M
Eisai 4523:JP Y 309633M 51213M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Exelixis EXEL:US $ 723.27M 76.1M
Genocea Biosciences GNCA:US $ 20.14M 17.01M
Geron GERN:US $ 31.32M 3.55M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Intra Cellular Therapies ITCI:US $ 129.29M 36.93M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Merk MRK:US $ 8556M 460M
Novartis NOVN:VX SF 13852M 1445M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M